Pasithea Therapeutics Corp. (KTTAW)
Pasithea Therapeutics Announces Exhibit atChildren’s Tumor Foundation 2026 NF Conference
Pasithea Therapeutics Announces Exhibit atChildren’s Tumor Foundation 2026 NF Conference
Pasithea Therapeutics Announces Exhibit at Children’s Tumor Foundation 2026 NF Conference
XORTX Provides Corporate Update and Announces Appointment of Mika Grasso as Co-CEO
Change - Change in Corporate Information: Liquidation of Indirect Wholly-Owned Subsidiaries
Coda Octopus Group Reports Fiscal Second Quarter 2026 Financial Results
American Express Announces Proposed Acquisition of TheFork, a Leading European Restaurant Booking Platform
Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman
Pebblebrook Hotel Trust Declares Dividends for Second Quarter 2026
Elicio Therapeutics Reports Results from Phase 2 AMPLIFY-7P Study and Outlines Refined Phase 3 Development Strategy for ELI-002 7P in Adjuvant Pancreatic Cancer
Sherritt Announces Exclusivity Agreement with Gillon Capital and Appointment of Independent Director